Almaviva Santè further expands its healthcare platform with two additional private hospitals

November 20, 2012

21 Partners is pleased to announce that Almaviva Santé Group, founded in 2007 and specialized in the private hospital sector, recently finalized the acquisition of two private clinics, Axium and Toutes Aures, both located in the Aix-en-Provence area in the south of France.

Axium is a multidisciplinary clinic widely recognized as one of the top performing medical establishments in its region. Axium has built a strong reputation on its specialization in interventional cardiology, orthopedics, ophthalmology, digestive surgery and urology. Axium records in excess of 22,000 annual patient admissions.

Toutes Aures has a diversified surgery activity and develops strong synergies with Axium, particularly in terms of sharing practitioners as well as medical and non-medical purchasing which represents an important source of value creation. Toutes Aures records in excess of 6,000 annual patient admissions.

Following these two acquisitions, the Group represents a hub of seven clinics, all top-rated in the south of France in terms of healthcare quality. Almaviva Santé developed a group quality standard policy allowing to receive the highest certifications and attract a growing number of patients. Moreover, purchasing and medical synergies have progressively been implemented leading to significant value creation through operational performance improvements. Almaviva Santé is determined to pursue expansion in the region through additional acquisitions while investing for the development of medical projects for the existing clinics.

Gérard Pluvinet, Founding Managing Partner and Henry Huyghues Despointes, Senior Partner at 21 Centrale Partners commented: “Since inception, the group has increased its revenues ninefold. With Almaviva, we have created a regional leader. It is a prime example of 21’s approach to platform consolidation strategies.”

ProductLife Group expands to India and Central Europe

After having acquired French-based AxPharma and US-based DS InPharmatics, PLG continues its dynamic development with this new build-up. It allows the group, acquired by 21 Invest France in 2019, to establish itself in India and strengthen its position in Central Europe, thus enhancing its value proposition with offshoring capacities.
Read more
Load More
Fail to load posts. Try to refresh page.